These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hypothesis of viscoreceptors: malfunction of viscoreceptors and viscosity-controllers in hypertension and polycythaemia. Dintenfass L Bibl Anat; 1977; (16 Pt 2):478-80. PubMed ID: 603588 [No Abstract] [Full Text] [Related]
4. Gaisböck's syndrome: its hematologic, biochemical and hormonal parameters. Stefanini M; Urbas JV; Urbas JE Angiology; 1978 Jul; 29(7):520-33. PubMed ID: 686487 [TBL] [Abstract][Full Text] [Related]
6. Stress polycythemia--a pathophysiologic study. El-Yousef MK; Bakewell WE South Med J; 1975 May; 68(5):559-64. PubMed ID: 165576 [TBL] [Abstract][Full Text] [Related]
7. Plasma renin and blood pressure during treatment with methyldopa. Weidmann P; Hirsch D; Maxwell MH; Okun R; Schroth P Am J Cardiol; 1974 Nov; 34(6):671-6. PubMed ID: 4422018 [No Abstract] [Full Text] [Related]
8. Effects of guanethidine and methyldopa on a standardized test for renin responsiveness. Lowder SC; Liddle GW Ann Intern Med; 1975 Jun; 82(6):757-60. PubMed ID: 1138585 [TBL] [Abstract][Full Text] [Related]
9. Late circulatory adjustments to acute normovolemic polycythemia. Weisse AB; Regan TJ; Nadimi M; Hellems HK Am J Physiol; 1966 Dec; 211(6):1413-8. PubMed ID: 5956558 [No Abstract] [Full Text] [Related]
10. Cerebral blood-flow and viscosity in relative polycythaemia. Humphrey PR; Du Boulay GH; Marshall J; Pearson TC; Russell RW; Symon L; Wetherley-Mein G; Zilkha E Lancet; 1979 Oct; 2(8148):873-7. PubMed ID: 90967 [TBL] [Abstract][Full Text] [Related]
11. ACTUAL AND PREDICTED-NORMAL RED-CELL AND PLASMA VOLUMES IN PRIMARY AND SECONDARY POLYCYTHAEMIA. HUME R; GOLDBERG A Clin Sci; 1964 Jun; 26():499-508. PubMed ID: 14191279 [No Abstract] [Full Text] [Related]
12. [Anti-hypertensive action of 3 drugs inhibiting the sympathetic nervous system. Hemodynamic and biological study]. Safar M; Corvol P; Weiss Y; Folliot A; Ménard J Nouv Presse Med; 1974 Apr; 3(14):871-5. PubMed ID: 4842508 [No Abstract] [Full Text] [Related]
13. Why is erythropoietin made in the kidney? The kidney functions as a critmeter. Donnelly S Am J Kidney Dis; 2001 Aug; 38(2):415-25. PubMed ID: 11479173 [TBL] [Abstract][Full Text] [Related]
14. Correlation of pathophysiology and pharmacotherapy in primary hypertension. Koch-Weser J Am J Cardiol; 1973 Sep; 32(4):499-510. PubMed ID: 4593182 [No Abstract] [Full Text] [Related]
15. Comparative study with prazosin, methyldopa and polythiazide in arterial hypertension. Marinković M; Vrhovac B; Kuzmanić D; Radonić M Int J Clin Pharmacol Biopharm; 1979 Jan; 17(1):38-47. PubMed ID: 367977 [No Abstract] [Full Text] [Related]
16. ACE inhibitors and cytoreductive therapy in polycythemia vera. Barbui T; Masciulli A; Ghirardi A; Carobbio A Blood; 2017 Mar; 129(9):1226-1227. PubMed ID: 28028024 [No Abstract] [Full Text] [Related]
17. Erythrocyte velocity and fluorescein transit time through the cerebral microcirculation in experimental polycythemia. Rosenblum WI J Neuropathol Exp Neurol; 1972 Jan; 31(1):126-31. PubMed ID: 5060127 [No Abstract] [Full Text] [Related]